abstract |
REFERS TO COMPOUNDS DERIVED FROM PIRAZOLE OF FORMULA (I) WHERE X, Y, R2 AND R3 ARE AS DEFINED IN THE DESCRIPTION. PREFERRED COMPOUNDS ARE: 3 - {(1S) -1 - [(2-AMINO-6,8-DIFLUOROQUINOLIN-3-IL) OXY] ETHYL} -4- (1H-PIRAZOL-1-IL) BENZOIC ACID; 6 - {(1S) -1 - [(2-AMINO-6-FLUOROQUINOLIN-3-IL) OXY] ETHYL} -5- (1H-PIRAZOL-1-IL) PYRIDIN-2-OL; AMONG OTHERS. ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS ARE HEMOGLOBIN (HB) MODULATORS, BEING USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY SICKLE HEMOGLOBIN (HBS) SUCH AS SICKLE CELL DISEASE (SCD). |